Acute myeloid leukemia (AML) is a hematological malignancy with an undefined heritable risk. Here we perform a meta-analysis of three genome-wide association studies, with replication in a fourth study, incorporating a total of 4018 AML cases and 10488 controls. We identify a genome-wide significant risk locus for AML at 11q13.2 (rs4930561; P = 2.15 × 10-8; KMT5B). We also identify a genome-wide significant risk locus for the cytogenetically normal AML sub-group (N = 1287) at 6p21.32 (rs3916765; P = 1.51 × 10-10; HLA). Our results inform on AML etiology and identify putative functional genes operating in histone methylation (KMT5B) and immune function (HLA)
Acute myeloid leukemia (AML) is a disease with marked heterogeneity in both response to therapy and ...
The purpose of this study was to conduct a two-stage case control association study including 654 ac...
BACKGROUND: Recent studies have provided a detailed census of genes that are mutated in acute myeloi...
Acute myeloid leukemia (AML) is a hematological malignancy with an undefined heritable risk. Here we...
Acute myeloid leukemia (AML) is a hematological malignancy with an undefined heritable risk. Here we...
International audienceAbstract The purpose of this study was to conduct a two-stage case control ass...
In recent years, our understanding of the molecular pathogenesis of myeloid neoplasms, including acu...
BACKGROUND: Many mutations that contribute to the pathogenesis of acute myeloid leukemia (AML) are u...
Acute myeloid leukemia (AML) is a disease with marked heterogeneity in both response to therapy and ...
The purpose of this study was to conduct a two-stage case control association study including 654 ac...
BACKGROUND: Recent studies have provided a detailed census of genes that are mutated in acute myeloi...
Acute myeloid leukemia (AML) is a hematological malignancy with an undefined heritable risk. Here we...
Acute myeloid leukemia (AML) is a hematological malignancy with an undefined heritable risk. Here we...
International audienceAbstract The purpose of this study was to conduct a two-stage case control ass...
In recent years, our understanding of the molecular pathogenesis of myeloid neoplasms, including acu...
BACKGROUND: Many mutations that contribute to the pathogenesis of acute myeloid leukemia (AML) are u...
Acute myeloid leukemia (AML) is a disease with marked heterogeneity in both response to therapy and ...
The purpose of this study was to conduct a two-stage case control association study including 654 ac...
BACKGROUND: Recent studies have provided a detailed census of genes that are mutated in acute myeloi...